IDEXX Labs (IDXX) Misses Q4 EPS Views; Nudges FY15 Outlook Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $672.04 --0%
Financial Fact:
Sales and marketing: 79.97M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Sales and marketing: 79.97M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $0.54, $0.26 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $352 million versus the consensus estimate of $373.2 million.
IDEXX Labs sees FY2015 EPS of $4.33 - $4.43, versus the consensus of $4.39. The company also sees 13.5 - 14.5 percent normalized organic revenue growth, an increase from prior views.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- Madison Square Garden Entertainment (MSGE) Tops Q1 EPS by 131c
- Medline Inc. (MDLN) Reports Q3 EPS of $0.44
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
